Results 281 to 290 of about 119,936 (354)

Nanotechnology Meets Immunotherapy: Crosstalks Against Cancer

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 5, May 2026.
ABSTRACT Background The convergence of nanotechnology and immunotherapy has ushered in a transformative era in cancer treatment, offering new strategies to overcome pharmacokinetic limitations and immune evasion associated with conventional therapies. While immunotherapy, spanning checkpoint inhibitors, adoptive cell transfer, and cancer vaccines, has ...
Nima Javanmehr   +4 more
wiley   +1 more source

Integrated Omics Approach to Delineate the Mechanisms of Doxorubicin-Induced Cardiotoxicity. [PDF]

open access: yesPharmaceuticals (Basel)
Dabour MS   +7 more
europepmc   +1 more source

BACH2 alleviates immune checkpoint inhibitors-induced cardiac pyroptosis via transcriptionally promoting GRSF1. [PDF]

open access: yesClin Transl Med
Cao M   +9 more
europepmc   +1 more source

Metabolomic Profiling of Tyrosine Kinase Inhibitor-Induced Endothelial Dysfunction and Cardiovascular Toxicity. [PDF]

open access: yesMetabolites
Singh G   +12 more
europepmc   +1 more source

Polyphenol-rich Cucurbita formulation mitigates doxorubicin-induced cardiotoxicity in rats: biochemical, histological, and molecular docking insights. [PDF]

open access: yesSci Rep
Iftikhar N   +11 more
europepmc   +1 more source

Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity

open access: yesCell, 2023
Mitochondrial DNA (mtDNA) is a potent agonist of the innate immune system; however, the exact immunostimulatory features of mtDNA and the kinetics of mtDNA detection by cytosolic nucleic acid sensors remain poorly defined.
Carl W Tong   +2 more
exaly   +2 more sources

Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity

open access: yesCell Metabolism, 2023
Fasting strategies are under active clinical investigation in patients receiving chemotherapy. Prior murine studies suggest that alternate-day fasting may attenuate doxorubicin cardiotoxicity and stimulate nuclear translocation of transcription factor EB
Mualla Ozcan, Zhen Guo, Carmen Bergom
exaly   +2 more sources

Home - About - Disclaimer - Privacy